Pharmaceuticals - The Times Of Central Asia

Viewing results 1 - 6 of 25

Healthcare Pharmaceuticals Export

Uzbekistan to Increase Production and Export of Medicines

Uzbekistan President Shavkat Mirziyoyev called a government meeting on 23 May to review plans for the country’s pharmaceutical industry. On 10 January, a road map for 2024–2025 was approved for the development of the pharmaceutical industry and the acceleration of related investment projects. This was followed by a presidential decree of 23 January which identified additional measures required to regulate the pharmaceutical sector. To date, a budget of $100 million has been allocated for the realization of new projects in the industry, boosted by an injection of $200 million from Asakabank. As a result, two projects worth $30.5 million have been launched over the past four months, with exports totalling $51 million. However, a lot of potential remains untapped. To redress the balance, plans are now underway to produce pharmaceutical products worth $400 million and increase the exports to $200 million. A total of 147 projects worth $2 billion will be launched this year alongside the commission of a further 28. The head of state emphasized the need to increase the level of domestically produced medicines available in Uzbekistan and to ensure a balance between price and quality. The meeting also reviewed measures to intensify the work of the innovative pharmaceutical cluster, Tashkent Pharma Park, by launching 12 projects worth $470 million.

Security Kazakhstan Central Asia Healthcare Pharmaceuticals Export/Import Economy Legislation

Kazakhstan Launches Battle against Counterfeit Medicines

From 1 July 1, 2024, in an effort to rid the country of counterfeit drugs flooding the local market, labeling of all medicines in Kazakhstan will become mandatory. According to the World Health Organization (WHO), every tenth package of medicines distributed in developing countries is counterfeit, and in Kazakhstan, exceeds 10% of the volume of imported medicines. This is not only an economic issue, but one that poses a direct threat to people's lives and the health of the nation. Under the new initiative, all drugs will be assigned an electronic passport detailing both its source and path to the consumer. The Ministry of Health of the Republic of Kazakhstan stated that the key aim of the project is to eradicate illegal trade in medicines, including those used within the state's medical programs and mandatory social health insurance. Confident that mandatory labeling will prove effective in dealing with gray imports in the pharmaceutical market, economist Andrei Chebotarev remarked, "When the manufacturer's goods are labeled, you can trace their route all the way to your home medicine cabinet. Everyone will know, for example, where the pills were produced and how they were imported into the country. At present, there is no guarantee that goods are genuine. Where was this medicine produced? In India, in Germany? It is almost impossible to check the source." In short, he continued, labeling is the surest way of "letting the cat out of the bag." Another positive impact of the introduction of labeling concerns an increase in tax revenues and customs duties. Pharmacies in Kazakhstan already sell drugs labeled with the DataMatrix code. Specialists believe that the pharmaceutical industry is ready to exit the shadow turnover. During the first two months of 2024, almost 5,000 tons of various drugs worth $275.7 million, were imported by Kazakhstan.

Kazakhstan Pharmaceuticals Kazakh-UK ties travel

British Companies Enter Commercial Agreements with Kazakhstan

Two new Kazakh-British business agreements were signed off during UK Foreign Secretary David Cameron’s visit to Kazakhstan on 24 April. The first, between AstraZeneca, a British-Swedish multinational pharmaceutical and biotechnology company, Kazakhstan’s Ministry of Healthcare, Almaty City Administration and Kazakh Invest, aims to implement an investment project for contract manufacturing of biotechnological products in Kazakhstan. According to Kazakh Invest, the agreement represents a significant step towards Kazakhstan’s goal to increase its share of domestically- produced medicines in the local market to 50%. The second deal, signed by the Ministry of Transport of Kazakhstan and British company Car Park Transformer, makes provision for the construction of roadside service facilities on Kazakhstan’s national and international highways. Comprising 250 service stations equipped with restrooms, retail spaces, as well as electric vehicle charging points, the project aims to provide essential services and enhance the comfort of motorists.

Pharmaceuticals Social Healthcare Kyrgyzstan

Kyrgyzstan Continues to Combat Drug Shortages

Health Minister of the Kyrgyz Republic, Alymkadyr Beishenaliyev has told local media that hospitals are 70-80% stocked with medicines, with hospitals in the Issyk-Kul region suffering the worst from short supplies. "There is a list of vital medicines, which we provide 100%. But doctors prescribe drugs which I, a medic, have never heard of; these are scarce drugs. Doctors used to get bonuses from private pharmacies [for prescribing them] - we are fighting this and it is impossible to change it in a short time," Beishenaliyev said. Kyrgyzstan's medical trade union reported that the country's hospitals lacked basic medicines and basic drugs. As of today, 290 medical organizations have applied for the necessary drugs, but are yet to receive them. Earlier this week, the Times of Central Asia reported about the difficult situation concerning the availability of drugs. Minister Beishenaliyev emphasized that the government is working to ensure hospitals have all the necessary drugs for the second quarter of 2024, promising that the problem would be resolved by 15 April. However, the head of Kyrgyzstan's medical trade union, Bermet Baryktabasova, criticized the statement made by the minister, saying that antibiotics, hormones, diuretics, anti-epileptic, psychotropic, cardiac and anti-asthma drugs are needed every day. It's medically advisable to have a three-month supply on hand, she said, adding that intensive care units need these drugs every minute, not next quarter. This year, to ensure timely and quality medical care, the Compulsory Medical Insurance Fund (CMIF) allocated 443.7 million sum ($5 million) for the purchase of medicines and medical devices.

Pharmaceuticals Central Asia Healthcare Uzbekistan

Cancer Patients in Uzbekistan Dying for Want of Palliative Care

Despite being approved back in 2017, the construction of a hospice for adults in Tashkent remains but a dream. Deprived of palliative care for the past five years, Uzbek citizens afflicted by oncological, haematological, neurological and immunological diseases have been left to suffer and die. Tasked with building the facility, the Comfort Engineering Group has defended the long delay by citing a lack of funds. Although allocated $1.4 million for the build, the company received only $113.5 thousand and as a consequence, was forced to down tools. The city administration had promised to finish the "long construction" back in November 2023 and in April this year, the hospice was expected to receive its first patients. Frustrated by the Uzbek capital's authorities, Yakhyo Ziyayev, oncologist and long-term campaigner for the development of palliative and hospice care in Uzbekistan, stated on social media, "I can honestly tell you, I'm losing faith in the possibility of changing anything for the better in this country. Here comes April. Where is the fulfilment of the promise? A week ago, Rustam (oncologist Rustam Norboev) and I visited the site. Nothing has started. We were told that it would start on Monday, next week. It's OK if they finish late, it's still a victory for us, so I didn't take it negatively." Local specialists have also voiced their disappointment, "Stephen Connor, head of the World Association for Hospice and Palliative Care, is due to visit Uzbekistan in May. But his visit will be pointless because of the lack of basic infrastructure." As a result of the high profile afforded to the oncologist's appeal, the Tashkent khokimiyat has now promised to discuss the issue with the city's recently appointed khokim, Shavkat Umurzakov, within 10-15 days. "If it is not possible to (secure) money to complete the hospice, they will get it from other sources and complete the hospice by September," assured an administration spokesperson. Thanks to the efforts of the Ezgu Amal Charitable Foundation, Israeli Ambassador to Uzbekistan Zehavit Ben-Hillel, Embassy employee Daphne Kfir-Furman and sponsors, Uzbekistan's first and only children's hospice opened in August 2022, has treated 260 patients to date.

Education Kyrgyzstan Central Asia Healthcare Pharmaceuticals Social

Kyrgyz Surgeons Performed Unique Heart Surgery in One Minute

The National Centre of Cardiology and Therapy in Bishkek has announced its implementation of an Emergency Cardiology program to provide emergency care to patients with acute myocardial infarction. The authorities' purchase of new heart surgery equipment including a machine to create ultra-precise 3D reconstructions of the heart on a monitor and the importation of U.S.-made Azurion-7 devices for diagnosing and treating cardiovascular diseases was made possible by the allocation of $1.5 million from the World Bank. In his address at the presentation ceremony, Kyrgyz Prime Minister Akylbek Japarov welcomed the much needed acquisition of the state -of -the- art, high-tech equipment which will greatly reduce the number of patients dying from heart disease each year. Today, the centre reported that with the aid of new high-tech X-ray surgical equipment and Chinese colleagues' specialised knowledge of its intricacies, doctors performed a successful heart operation in a record time of just one minute and eight seconds. According to Kyrgyz doctors, the patient had been admitted 'with an open oval window'; a particularly dangerous symptom of cardiovascular disease because the presence of holes between the valves of the heart can cause air to eventually enter the brain and lead to a stroke. "We are monitoring the patient's condition and she is doing very well. She was only given a local anaesthetic and in 12 hours, can go home and slowly return to her everyday life," stated Chinese professor Shang Xiaaoqe after the operation. Almost half the patients attending the National Centre of Cardiology for strokes suffer from this type of disease but thanks to the new equipment and adoption of methods used by Chinese medics, its treatment will no longer pose a problem for Kyrgyz doctors. In addition to advice from their Chinese counterparts, Kyrgyz medics have arranged visits from Russian and Kazakh doctors to share their experience and best practices.